Actions and potential therapeutic applications of growth hormone-releasing hormone agonists
But studies of GLP-1 patients have shown that muscle loss also occurs, which for athletes, would do the opposite of enhancing performance
This broad receptor activity makes it uniquely valuable as a pharmacological probe for studying the full melanocortin system in preclinical research, while also contributing to its broader side-effect profile
Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M, et al
[2] In addition, it may not only trigger the expression of insulin-like growth factor-1(IGF-1) but may also inhibit the secretion of somatostatin